Croda International announced a new strategic partnership. Croda has agreed a commercial arrangement with SiSaf, a UK based bio-pharmaceutical company. The arrangement involves the use and development of SiSaf’s patented bio-courier, ProSilic, a novel drug delivery technology. Croda has also acquired a minority shareholding in SiSaf.

ProSilic will give Croda’s customers access to the next generation of targeted and controlled drug delivery, which can be tailored to meet their specific needs, whilst offering exceptional safety and versatility. This sustainable technology uses biodegradable silicon particles to improve stability, solubility and ultimately the performance of a wide range of active ingredients across many delivery systems.

Croda’s investment is a contributor to SiSaf’s latest round of capital funding that will enable them to accelerate a commercial route to market for this unique technology. While the partnership will primarily focus on Croda’s Health Care market, the diversity of ProSilic technology will see research projects take place in much wider applications.

"The cultural fit between Croda and SiSaf, with a strong focus on innovation and sustainability, means that this strategic partnership will bring great benefits to our customers and their formulations," Dr. Nick Challoner, President Life Sciences, Croda, said. "We are hugely excited that through this investment we will be able to exclusively bring this novel, patented technology to our Health Care customers worldwide, enabling them to enhance the performance of their products."

"This is more than an investment of capital. It is an investment in our belief that good science equals good business. Our strategic partnership with Croda will turn potential into reality much faster than SiSaf could have achieved alone," Dr. Suzanne Saffie-Siebert, Founder and CEO of SiSaf, said. "We are extremely proud to be working with such an impressive organisation to boost the development of ProSilic technology and together I am sure we will exceed the expectations of Croda’s customers worldwide."

 --------------------------------------------------------------------------------------------------------------------------

Editor's Note:

To apply for becoming a contributor of en-CPhI.cn,

welcome to send your CV and sample works to us,

Email: Julia.Zhang@ubmsinoexpo.com.